- Home
- WTBA vs AGEN Comparison
WTBA vs AGEN Comparison
Compare WTBA & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | AGEN |
|---|---|---|
| Founded | 1893 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 342.0M | 126.2M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | WTBA | AGEN |
|---|---|---|
| Price | $22.60 | $3.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $23.50 | $14.50 |
| AVG Volume (30 Days) | 36.5K | ★ 628.7K |
| Earning Date | 01-29-2026 | 11-10-2025 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | ★ 49.53 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | $91,783,000.00 | ★ $106,829,000.00 |
| Revenue This Year | $25.05 | $67.15 |
| Revenue Next Year | $10.87 | N/A |
| P/E Ratio | $11.90 | ★ N/A |
| Revenue Growth | ★ 19.66 | N/A |
| 52 Week Low | $17.31 | $1.38 |
| 52 Week High | $24.27 | $7.34 |
Technical Indicators
Market Signals| Indicator | WTBA | AGEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 26.63 |
| Support Level | $23.47 | $3.26 |
| Resistance Level | $22.82 | $4.00 |
| Average True Range (ATR) | 0.53 | 0.25 |
| MACD | -0.15 | -0.06 |
| Stochastic Oscillator | 25.58 | 14.86 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).